Medicamentos de actualidad = Drugs of today

• 

  Año 2011, Vol. 47, Número 11

  • Monographs

    • Lurasidone: a new treatment option for schizophrenia.

      Richard T. Owen

      págs. 807-816

      

    • Ruxolitinib for the treatment of myelofibrosis.

      Alen Ostojic, Radovan Vrhovać, Srdan Verstovsek

      • Resumen

      págs. 817-827

      

    • Telaprevir: looking for a sustained virologic response in hepatitis C virus infection.

      Vandana Nehra, Stacey A. Rizza, Rohit Talwani, Zelalem Temesgen

      • Resumen

      págs. 829-837

      

  • Reviews

    • An update on exenatide, a novel therapeutic option for patients with type 2 diabetes.

      Winston Crasto, Kamlesh Khunti, Melanie J. Davies

      • Resumen

      págs. 839-856

      

    • Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib).

      Daniel W. Bowles, Elizabeth R. Kessler, Antonio Jimeno

      • Resumen

      págs. 857-868

      

  • Meeting Report

    • A report from the 2011 Alzheimer's Association International Conference (July 16-21 - Paris, France)

      Xavier Rabasseda, Coia Dulsat

      • Resumen

      págs. 869-878